HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Board Certifications: Hematology, Internal Medicine and Medical Oncology
Languages: English, Hindi and Punjabi
Locations: Freehold, NJ, Holmdel, NJ and Toms River, NJ – Bey Lea Road (Bldg A – Lamba/Henningson)
Dr. Gurpreet Singh Lamba specializes in hematology and oncology and is board certified in internal medicine, hematology and clinical oncology. He has been treating patients with compassion in the Toms River and Freehold locations since 2014. Dr. Lamba has always been an outstanding student and trainee. He has earned various prestigious academic awards and honors, and has been involved in research throughout his training. He has published many review and research articles in peer-reviewed journals. Dr. Gurpreet also enjoys teaching and is involved in training fellows and residents
Jawaharlal Nehru Medical College (JNMC), Belgaum, India
July 2006 – June 2009 – Internal Medicine, New York Medical College at Westchester Medical Center, Valhalla, N.Y
July 2009 – June 2012 – Hematology / Oncology, New York Medical College at Westchester Medical Center, Valhalla, N.Y
American Society of Hematology, American Society of Clinical Oncology, Association of Physicians of Indian Origin (AAPI), Monmouth and Ocean County Association of Physicians of Indian Origin (MOCAAPI), Treasurer, Monmouth and Ocean County – Association of Physicians of Indian Origin (MOCAAPI), 2017-2019
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.